Variant report
Variant | esv3401139 |
---|---|
Chromosome Location | chr2:114793129-114817730 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs188036 | chr2:114793151-114793152 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs549583460 | chr2:114793179-114793180 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs563119270 | chr2:114793200-114793201 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs150143997 | chr2:114793222-114793223 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs371069785 | chr2:114793235-114793236 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs183160408 | chr2:114793245-114793246 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs565922483 | chr2:114793267-114793268 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs187888714 | chr2:114793527-114793528 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs533943412 | chr2:114793538-114793539 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs563188628 | chr2:114793539-114793540 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs567668798 | chr2:114793550-114793551 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs536728556 | chr2:114793554-114793555 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs192306851 | chr2:114793586-114793587 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs184267922 | chr2:114793606-114793607 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs539381493 | chr2:114793623-114793624 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs529007361 | chr2:114793627-114793628 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs558999496 | chr2:114793646-114793647 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs572655987 | chr2:114793656-114793657 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs187628003 | chr2:114793661-114793662 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs113141792 | chr2:114793667-114793668 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs370136360 | chr2:114793722-114793723 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs545738149 | chr2:114793726-114793727 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs192846470 | chr2:114793742-114793743 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs566299610 | chr2:114793775-114793776 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs563956057 | chr2:114793818-114793819 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs142893133 | chr2:114793868-114793869 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs532182765 | chr2:114793873-114793874 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs147021199 | chr2:114793888-114793889 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs559409223 | chr2:114793923-114793924 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs528351665 | chr2:114793951-114793952 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs547506958 | chr2:114794002-114794003 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs376453684 | chr2:114794049-114794050 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs528759759 | chr2:114794056-114794057 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs530266118 | chr2:114794073-114794074 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs139021187 | chr2:114794109-114794110 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs551706242 | chr2:114794110-114794111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs72956228 | chr2:114794138-114794139 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs143030647 | chr2:114794173-114794174 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs559082133 | chr2:114794269-114794270 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs566261048 | chr2:114794279-114794280 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs535313068 | chr2:114794280-114794281 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs554314129 | chr2:114794305-114794306 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs574083858 | chr2:114794310-114794311 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs542970660 | chr2:114794346-114794347 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs199826597 | chr2:114794359-114794360 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs371286569 | chr2:114794390-114794391 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs144718756 | chr2:114794402-114794403 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs184266499 | chr2:114794437-114794438 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs545694525 | chr2:114794439-114794440 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs188998934 | chr2:114794509-114794510 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroticism | 17667963 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:114790800-114798400 | Weak transcription | Fetal Brain Male | brain |
2 | chr2:114797200-114799400 | Enhancers | Fetal Brain Female | brain |
3 | chr2:114798400-114798800 | Enhancers | Pancreas | Pancrea |
4 | chr2:114798400-114799200 | Enhancers | Fetal Brain Male | brain |
5 | chr2:114799200-114804000 | Weak transcription | Fetal Brain Male | brain |
6 | chr2:114804000-114805600 | Enhancers | Fetal Brain Male | brain |
7 | chr2:114806400-114808000 | Enhancers | HMEC | breast |
8 | chr2:114806400-114808200 | Enhancers | NHEK | skin |
9 | chr2:114806800-114807800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
10 | chr2:114806800-114808000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
11 | chr2:114813600-114814200 | Enhancers | GM12878-XiMat | blood |
12 | chr2:114813800-114814000 | Enhancers | Rectal Mucosa Donor 29 | rectum |
13 | chr2:114813800-114815200 | Enhancers | Rectal Mucosa Donor 31 | rectum |
14 | chr2:114814000-114814200 | Enhancers | Sigmoid Colon | Sigmoid Colon |
15 | chr2:114814200-114815200 | Weak transcription | Sigmoid Colon | Sigmoid Colon |
16 | chr2:114815200-114815600 | Active TSS | Rectal Mucosa Donor 31 | rectum |
17 | chr2:114815200-114816000 | Active TSS | Rectal Mucosa Donor 29 | rectum |
18 | chr2:114815200-114816000 | Enhancers | Sigmoid Colon | Sigmoid Colon |
19 | chr2:114815600-114816000 | Flanking Active TSS | Rectal Mucosa Donor 31 | rectum |